Delivery Order SPE2DE21D7010-SPE2D626F53H4
- Not listed
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $4,682.23 on December 5, 2025, for RELINE MAS IMPLANTS through the Defense Logistics Agency (DLA) Medical Supply Chain. The contract is structured as a fixed-price delivery order with economic price adjustment provisions and carries an ultimate completion date of December 30, 2025. No set-aside designation was used in this competitive procurement....
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order valued at $15,124.90 on November 12, 2025, for RELINE MAS IMPLANTS under contract number 4569992779. The contract utilizes fixed-price pricing with economic price adjustment mechanisms and carries an ultimate completion date of December 3, 2025. This delivery order was issued without set-aside designation through the Defense Logistics Agency Medical Supply...
- Nuvasive, Inc., a San Diego-based medical device manufacturer, was awarded a $13,362.36 fixed-price delivery order (Contract No. 4570340917) on December 10, 2025, for the RELINE-C spinal implant system, with performance scheduled for completion by December 11, 2025, at the company's San Diego, California facility. The contract was funded through the Defense Logistics Agency Medical Supply Chain without set-aside designation, reflecting open competition among qualified medical device suppliers....
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a fixed-price delivery order valued at $12,607.94 by the Defense Logistics Agency (DLA) Medical Supply Chain on December 12, 2025. This delivery order, with an ultimate completion date of January 5, 2026, covers the procurement of RELINE OPEN IMPLANTS—specialized spinal surgical implants designed to support advanced orthopedic and neurosurgical procedures. The award was...
- Nuvasive, Inc. was awarded a $13,808.82 fixed-price delivery order by the Defense Logistics Agency (DLA) Medical Supply Chain on October 14, 2025, for the procurement of RELINE MAS implants, with performance scheduled to conclude by November 3, 2025. The award was made without a set-aside designation, indicating open competition. The contract utilizes a fixed-price structure with economic price adjustment mechanisms, supporting the delivery of specialized spinal medical technology to federal...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a delivery order on November 3, 2025, for RELINE MAS IMPLANTS with a ceiling value of $22,376.93 and an ultimate completion date of November 24, 2025. This fixed-price contract with economic price adjustment was issued without set-aside designation by the Defense Logistics Agency Medical Supply Chain, a component of the Department of Defense responsible for procuring medical...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $12,646.10 fixed-price delivery order (Contract #4570184048) on December 2, 2025, for RELINE OPEN IMPLANTS. This delivery order, issued without set-aside designation, is funded through the Defense Logistics Agency Medical Supply Chain and includes an economic price adjustment mechanism to address cost fluctuations. Performance is scheduled for completion by December 3,...
- Nuvasive, Inc., a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc., was awarded a $12,607.94 fixed-price delivery order (contract number 4570040417) by the Defense Logistics Agency Medical Supply Chain on November 13, 2025, for RELINE OPEN IMPLANTS to be delivered by December 5, 2025. The contract was awarded without set-aside designation through open market competition and includes an economic price adjustment mechanism to accommodate cost fluctuations....
- Nuvasive, Inc., a San Diego-based medical device company specializing in spinal surgery products, received a delivery order award from the Defense Logistics Agency (DLA) Medical Supply Chain for RELINE MAS implants valued at $11,751.69. The contract, awarded on August 25, 2025, with an ultimate completion date of August 26, 2025, utilizes a fixed-price with economic price adjustment pricing structure and includes no set-aside designation, indicating open market competition. This delivery order...
- Nuvasive, Inc., a San Diego-based medical device company specializing in spinal surgery products and implants, was awarded a $12.43K fixed-price delivery order with economic price adjustment for RELINE MAS IMPLANTS by the Defense Logistics Agency (DLA) Medical Supply Chain on September 9, 2025. The contract, with an ultimate completion date of October 3, 2025, carries no set-aside designation, indicating open market competition. Performance will take place in San Diego, California. This delivery...
- SPE2DE21D7010Indefinite Delivery Contract
- SPE2DE21D7010-SPE2D626F53H4Delivery Order
Nuvasive, Inc. received a $11,751.69 delivery order from the Defense Logistics Agency (DLA) Medical Supply Chain on December 12, 2025, for RELINE MAS IMPLANTS with an ultimate completion date of January 14, 2026. The contract utilizes a fixed-price pricing structure with economic price adjustment provisions and was awarded without set-aside restrictions, reflecting Nuvasive's successful competition in open market federal procurements. Performance will be conducted at Nuvasive's facility in San Diego, California. This delivery order is issued under Nuvasive's parent company, Transplant Technology Inc., which maintains an $8 million Blanket Purchase Agreement (BPA) with the Defense Health Agency structured as an Indefinite Delivery/Indefinite Quantity (IDIQ) contract vehicle effective through March 2027. RELINE MAS IMPLANTS are advanced spinal fusion and reconstruction devices within Nuvasive's comprehensive portfolio of orthopedic and neurosurgical technologies that support Department of Defense and Department of Veterans Affairs healthcare missions. Nuvasive, a San Diego-based medical device manufacturer and subsidiary of Transplant Technology Inc.'s Bone Bank Allografts division, serves as a critical supplier to federal healthcare agencies, providing specialized spinal implants, bone graft materials, and surgical instrumentation. The DLA Medical Supply Chain, which procures medical supplies and equipment for military and veteran healthcare facilities, has issued the overwhelming majority of Nuvasive's federal contract awards. The typical delivery timeframe for such orders spans weeks to months, reflecting the urgent medical supply requirements of the military health system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.8k | 12/11/25 |